Physician profile
Jay Freilich
NPI 1376679035
$2,374.61
in general payments reported to CMS, 2019-2025
12 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $800 · 2021: $24.67 · 2023: $16.72 · 2024: $94.91 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,200 · Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,200.00 |
| Food and Beverage | $181.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,200.00 | 2025 | Bd Intelliport |
| Baxter Healthcare | $800.00 | 2020 | |
| Mallinckrodt Enterprises LLC | $124.99 | 2019 | |
| Janssen Biotech, INC. | $47.16 | 2023-2025 | Tremfya, Simponi Aria, Remicade |
| Heron Therapeutics, INC. | $46.49 | 2024 | Aponvie |
| Celgene Corporation | $28.71 | 2024 | Zeposia |
| Redhill Biopharma INC. | $24.67 | 2021 | |
| Intercept Pharmaceuticals, INC. | $23.89 | 2025 | |
| Masimo Corporation | $23.81 | 2019 | |
| Exact Sciences Corporation | $19.71 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $19.52 | 2019 | |
| Lilly USA, LLC | $15.66 | 2025 | Omvoh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Freilich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.